BioGend Therapeutics Market Cap

BioGend Therapeutics has a market cap or net worth of 4.22 billion as of February 21, 2025. Its market cap has decreased by -11.30% in one year.

Market Cap

4.22B

Enterprise Value

3.60B

Revenue

156.64M

Ranking

n/a

PE Ratio

n/a

Stock Price

33.65

Market Cap Chart

Since June 18, 2019, BioGend Therapeutics's market cap has increased from 2.71B to 4.22B, an increase of 55.65%. That is a compound annual growth rate of 8.09%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	4.22B	1.04%
Dec 31, 2024	4.18B	-11.18%
Dec 29, 2023	4.71B	109.50%
Dec 30, 2022	2.25B	-18.50%
Dec 30, 2021	2.76B	-22.86%
Dec 31, 2020	3.57B	46.27%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	226.03B
Caliway Biopharmaceuticals	145.92B
Bora Pharmaceuticals Co., LTD.	90.53B
Lotus Pharmaceutical	72.59B
Lumosa Therapeutics	39.94B
Oneness Biotech	38.77B
Polaris Group	36.53B
Pegavision	30.34B

Market Cap Rankings